Skip to main navigation
Skip to search
Skip to main content
UK Health Security Agency Main
Search content at UK Health Security Agency
Main
Profiles
Research units
Projects
Research output
Prizes
Activities
Impacts
Infection control measures to limit the spread of Clostridium difficile
R. P. Vonberg
*
, E. J. Kuijper
, M. H. Wilcox
, F. Barbut
, P. Tüll
, P. Gastmeier
, P. J. Van Den Broek
, A. Colville
, B. Coignard
, T. Daha
, S. Debast
, B. I. Duerden
, S. van den Hof
, T. van der Kooi
, H. J.H. Maarleveld
, E. Nagy
, D. W. Notermans
, J. O'Driscoll
,
B. Patel
, S. Stone
C. Wiuff
Show 1 more
Show less
*
Corresponding author for this work
London Lab
Research output
:
Contribution to journal
›
Article
›
peer-review
268
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Infection control measures to limit the spread of Clostridium difficile'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clostridioides Difficile
100%
Infection Control Measures
100%
Clostridium Difficile-associated Diarrhea
100%
C. Difficile
83%
Environmental Cleaning
33%
Hand Hygiene
16%
Early Diagnosis
16%
Antimicrobial Therapy
16%
Hypervirulent Strain
16%
Severe Disease
16%
Patient Outcomes
16%
Inappropriate Use
16%
Antibiotic Prescribing
16%
Nosocomial Infection
16%
Selective Pressure
16%
Protective Clothing
16%
Cleaning Agents
16%
Local Practices
16%
Antibiotic Stewardship
16%
Evidence-based Guidelines
16%
Alcohol-based
16%
Local Protocol
16%
Medical Equipment
16%
Hand Disinfection
16%
Isolation Precautions
16%
Nursing and Health Professions
Infection Control
100%
Clostridium Difficile Infection
100%
Practice Guideline
16%
Hand Washing
16%
Antimicrobial Stewardship
16%
Antimicrobial Therapy
16%
Early Diagnosis
16%
Treatment Outcome
16%
Hospital Infection
16%
Medical Device
16%
Hand Disinfection
16%
Protective Clothing
16%
Antimicrobial Agent
16%
Diseases
16%
Education
16%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Clostridium Difficile Infection
100%
Peptoclostridium difficile
100%
Antimicrobial Agent
33%
Antimicrobial Therapy
16%
Hospital Infection
16%
Diseases
16%